ArticlePloS one2024

Virologic outcomes on dolutegravir-, atazanavir-, or efavirenz-based ART in urban Zimbabwe: A longitudinal study.

Tinei Shamu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.